Novartis Investigative Site

Jining, Shandong 272000

2 studies enrolling now · 4 studies all time

What they study most

Atherosclerotic Cardiovascular Disease (ASCVD), Early Breast Cancer, Metastatic Pancreatic Ductal Adenocarcinoma, Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD — Recruiting now
• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2 — Completed